
Invicta Diagnostic Limited IPO
NSE SME₹ 272000 /3200 Shares
*Min Investment
01 Dec, 2025
Open Date03 Dec, 2025
Close Date04 Dec, 2025
Allotment Date08 Dec, 2025
Listing DateInvicta Diagnostic IPO Issue Details
- Issue Price ₹80-85 per equity share
- Face Value ₹10 Per Equity Share
- Total Issue Size 33,08,800 shares(aggregating up to ₹28.12 crore)
- Fresh Share 33,08,800 shares(aggregating up to ₹28.12 crore)
- Listing at NSE SME
- Lead Manager Socradamus Capital Pvt Ltd
- Registrar Bigshare Services Pvt Ltd
Market Lot Size
Investors can bid for a minimum of 3200 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual (min) | 2 | 3200 | ₹2,72,000 |
| Individual(max) | 2 | 3200 | ₹2,72,000 |
| SHNI(min) | 3 | 4800 | ₹4,08,000 |
| SHNI(max) | 7 | 11,200 | ₹9,52,000 |
| BHNI(min) | 8 | 12,800 | ₹10,88,000 |
Invicta Diagnostic IPO Reservation
Invicta Diagnostic IPO offers total 0 shares. Out of which NA (NA%) allocated to QIB, 0 (NA%) allocated to NII,0 (NA%) allocated to RII, NA (NA%) allocated to employees and NA (NA%) allocated to Anchor investors.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| Anchor Investor Shares Offered | NA (NA%) | |
| Market Maker Shares Offered | NA (NA%) | |
| QIB Shares Offered | NA (NA%) | |
| NII (HNI) Shares Offered | 0 (NA%) | |
| Individual Shares Offered | 0 (NA%) | |
| Total Shares Offered | 0 (100%) |
Invicta Diagnostic IPO Documents
Invicta Diagnostic IPO Details
Invicta Diagnostic Limited IPO is an SME IPO, priced at ₹80-85 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform. The IPO comprises a total issue of 33,08,800 equity shares, aggregating up to ₹28.12 crores..
The IPO bidding window is open from Dec 1, 2025 to Dec 3, 2025. The allotment is expected to be finalized on Dec 4, 2025, and the tentative listing date is Dec 8, 2025.
The minimum lot size for Individual investors is 3200 shares, with a minimum investment of ₹2,72,000.
Socradamus Capital Pvt Ltd is acting as the lead manager to the issue. The registrar of the IPO is Bigshare Services Pvt Ltd, and
Invicta Diagnostic Valuations
Invicta Diagnostic Company Financials
| 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | |
|---|---|---|---|
| Assets | 21.22 | 15.89 | N/A |
| Revenue | 30.18 | 15.90 | N/A |
| Profit After Tax | 4.93 | 3.81 | N/A |
| Net Worth | 13.60 | 8.67 | N/A |
| Reserves & Surplus | 5.18 | 8.54 | N/A |
| Total Borrowing | 3.54 | 3.81 | N/A |
About Invicta Diagnostic Company
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra.
Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West
Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services
Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa.
It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations.
Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes:
Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels.
Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Invicta Diagnostic - Promoter(s)
Dr. Ketan Jayantilal Jain
Dr. Sanket Vinod Jain
Rohit Prakash Srivastava
Badal Kailash Naredi
Jayesh Prakash Jain
Pre Issue Share Holding : %
Post Issue Share Holding : %
Invicta Diagnostic IPO - Issue Objectives
Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra
General Corporate purposes
Contact Details
Invicta Diagnostic
1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road, Mumbai, Maharashtra, 400013
022-4971-0036
Registrar Contact Details
Bigshare Services Pvt Ltd
+91-22-6263 8200
Invicta Diagnostic IPO - FAQs
Ans. Invicta Diagnostic Limited IPO is a SME IPO. The issue is priced at ₹80-85 per equity share. The minimum order quantity is 1600 Shares. The IPO opens on Dec 1, 2025, and closes on Dec 3, 2025. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The Invicta Diagnostic Limited IPO opens on Dec 1, 2025 and closes on Dec 3, 2025.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Invicta Diagnostic Limited IPO is 33,08,800 shares(aggregating up to ₹28.12 Cr).
Ans. The Invicta Diagnostic Limited IPO price band is set between ₹80-85 per equity share.
Ans. To apply for Invicta Diagnostic Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Invicta Diagnostic Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Invicta Diagnostic Limited IPO is Dec 4, 2025.
Ans. The Invicta Diagnostic Limited IPO will be listed on Dec 8, 2025.
Ans. Follow the steps to check the Invicta Diagnostic Limited IPO allotment status online.